Uusküla Anneli, McNutt Louise Anne, Dehovitz Jack
Department of Public Health, University of Tartu, Veski st. 26-3, Tartu 50409, Estonia.
Sex Transm Dis. 2004 Oct;31(10):631-5. doi: 10.1097/01.olq.0000140022.34441.e3.
Estonia is among those Eastern European countries that have witnessed an explosive intravenous drug use-driven HIV epidemic. Early sexually transmitted disease (STD) diagnosis and appropriate treatment is essential to prevent an STD-driven HIV epidemic.
The objectives of this study were to define the schedule of antibiotic treatment doctors in Estonia used to treat STDs, and to determine if the treatments used correspond to evidence-based medicine treatment principles.
Using an administrative database of the Estonian Health Insurance Fund on pharmaceuticals reimbursement, we obtained information on: drug (ATC 1998) prescribed with an STD diagnosis (International Classification of Diseases and Related Health Problems, syphilis, gonorrhea, genital Chlamydia trachomatis and Trichomonas vaginalis infections, and genital herpes), prescribing physician specialty, and patient demographics (date of birth, gender). To evaluate the correspondence of STD treatment to evidence-based medicine principles, the therapeutic regimens used were compared with recommendations from the European Sexually Transmitted Infections Management Guidelines.
In 2001 and 2002, physicians ordered 17,077 prescriptions for systemic antibacterial medications to treat STDs in 12,823 different individuals: 2942 men (mean age, 31.8 years) and 9880 women (mean age, 29.5 years). The majority of STD treatments were prescribed by gynecologists (60%) or dermatovenerologists (29%); general practitioners treated 8% of STDs. In 11% of treatment episodes, the drug prescribed was inconsistent with guideline recommendations; additionally, in 9% of episodes, the recommended drug was chosen but the prescribed dose was too low. At least 20% of treatment episodes could therefore be considered inappropriate.
Educational efforts are needed to increase physician awareness of evidence-based approaches for STD management and treatment to assure effective STD care.
爱沙尼亚是那些目睹了由静脉注射毒品驱动的艾滋病病毒疫情爆发的东欧国家之一。早期性传播疾病(STD)诊断和适当治疗对于预防由性传播疾病驱动的艾滋病病毒疫情至关重要。
本研究的目的是确定爱沙尼亚医生用于治疗性传播疾病的抗生素治疗方案,并确定所使用的治疗方法是否符合循证医学治疗原则。
利用爱沙尼亚健康保险基金药品报销的行政数据库,我们获得了以下信息:诊断为性传播疾病(国际疾病和相关健康问题分类,梅毒、淋病、生殖道沙眼衣原体和阴道毛滴虫感染以及生殖器疱疹)时所开的药物(1998年解剖治疗化学分类系统)、开处方医生的专业以及患者人口统计学信息(出生日期、性别)。为了评估性传播疾病治疗与循证医学原则的符合程度,将所使用的治疗方案与《欧洲性传播感染管理指南》的建议进行了比较。
在2001年和2002年,医生为12823名不同个体开具了17077份用于治疗性传播疾病的全身抗菌药物处方:2942名男性(平均年龄31.8岁)和9880名女性(平均年龄29.5岁)。大多数性传播疾病治疗处方由妇科医生(60%)或皮肤性病科医生(29%)开具;全科医生治疗了8%的性传播疾病。在11%的治疗病例中,所开药物与指南建议不一致;此外,在9%的病例中,选择了推荐药物但所开剂量过低。因此,至少20%的治疗病例可被视为不恰当。
需要开展教育工作,以提高医生对性传播疾病管理和治疗循证方法的认识,以确保有效的性传播疾病护理。